Defining Human Pluripotency.Cell Stem Cell25, 9-22.(2019).
Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells.Cell Stem Cell25, 419-432.e9.(2019).
FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo.Cell Rep26, 2531-2539.e4.(2019).
Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells.Iscience11, 398-408.(2019).
Derivation and molecular characterization of pancreatic differentiated MODY1-iPSCs.Stem Cell Res31, 16-26.(2018).
Mice from Same-Sex Parents: CRISPRing Out the Barriers for Unisexual Reproduction.Cell Stem Cell23, 625-627.(2018).
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq.Nat Commun7, 12144.(2016).
Quality control: Genome maintenance in pluripotent stem cells.J Cell Biol204, 153-63.(2014).
Global Indiscriminate Methylation in Cell-Specific Gene Promoters following Reprogramming into Human Induced Pluripotent Stem Cells.Stem Cell Reports1, 509-17.(2013).
Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells.Stem Cell Reports1, 79-89.(2013).